In line with the above results, Fetz et al [37] showed that low NO levels conferred survivin-mediated resistance against cisplatin/taxol-induced apoptosis in head and neck squamous cell carcinoma lines. Here, BIRC5 is linked to head and neck squamous cell carcinoma.